AQP8 | Aquaporin 8 | Predicted membrane proteins Transporters
| | | | | Group enriched |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SPACA3 | Sperm acrosome associated 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
KLK1 | Kallikrein 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
TEX11 | Testis expressed 11 | | | | | | Group enriched |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | | | | Group enriched |
C14orf105 | Chromosome 14 open reading frame 105 | | | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CFC1 | Cripto, FRL-1, cryptic family 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
CFC1B | Cripto, FRL-1, cryptic family 1B | Predicted secreted proteins
| | | | | Group enriched |
FAM159B | Family with sequence similarity 159, member B | Predicted membrane proteins
| | | | | Group enriched |
RP11-664D7.4 | HCG1787533; Uncharacterized protein | | | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
LHFPL5 | Lipoma HMGIC fusion partner-like 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
REG3G | Regenerating islet-derived 3 gamma | Predicted secreted proteins
| | | | | Group enriched |
CELA1 | Chymotrypsin-like elastase family, member 1 | Enzymes
| | | | | Group enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LEFTY1 | Left-right determination factor 1 | Predicted secreted proteins
| | | | | Group enriched |
NGB | Neuroglobin | | | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A31 | Solute carrier family 22, member 31 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM52 | Transmembrane protein 52 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GUCA1C | Guanylate cyclase activator 1C | | | | | | Group enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | | | Group enriched |
PKHD1 | Polycystic kidney and hepatic disease 1 (autosomal recessive) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
C1orf127 | Chromosome 1 open reading frame 127 | Predicted secreted proteins
| | | | | Group enriched |
GAMT | Guanidinoacetate N-methyltransferase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |